Delivery Order SPE2DB22D1017-SPE2DB24FG5HP

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $69K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the TWINRIX vaccine. The $7,668.94 firm-fixed-price contract has an ultimate completion date of August 20, 2024. AmerisourceBergen, through its Corporate Office division, will provide the TWINRIX vaccine syringes to support the DLA's medical supply requirements. This order is placed under an Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,535.96, is for the procurement of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract is a firm fixed-price delivery order with a completion date of March 25, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,147.22 firm fixed-price contract is for the supply of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The $1,379.16 firm fixed price contract has a completion date of July 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $131,101.44 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,125.68, with an ultimate completion date of October 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,639.25, is for the supply of TWINRIX vaccine syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The $11,306.59 firm fixed-price contract has a completion date of June 18, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides global pharmaceutical support to military healthcare programs through December 2026. The contract is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The $1,340.32 firm fixed-price contract has a completion date of July 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $131,101.44 firm fixed-price contract provides the TWINRIX VACCINE SYRINGE ML product to support military healthcare programs. The contract has an ultimate completion date of June 5, 2024 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5HP
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation's Corporate Office division. The $68,733.44 firm fixed-price contract is for the supply of TWINRIX vaccine syringes. The order is placed under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. This IDC serves as a primary vehicle for AmerisourceBergen to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/18/24, 9:16 AM